REPORTS

Let’s Pullulate and Expand Your Business

Dermatology Drug Market - Global Professional Analysis and Forecast to 2026

Nov 18, 2019  |  203 PAGES  |  REPORT CODE: CMM241177
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Dermatology Drug market was valued at 21024 Million US$ in 2018 and is projected to reach 38512 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.86% during the forecast period.

This report presents the market size and development trends by detailing the Dermatology Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Dermatology Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Dermatology Drug industry and will help you to build a panoramic view of the industrial development.

Dermatology Drug Market, By Type:

  • External Use

  • Oral

  • Injection

Dermatology Drug Market, By Application:

  • Psoriasis

  • Skin Infections

  • Acne

  • Dermatitis

  • Other

Some of the leading players are as follows:

  • AbbVie

  • Pfizer

  • Bayer

  • Valeant

  • Novartis

  • Johnson & Johnson

  • GlaxoSmithKline

  • Bristol-Myers Squibb

  • Galderma

  • Merz Pharma

  • LEO Pharma

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Dermatology Drug Market: Technology Type Analysis

  • 4.1 Dermatology Drug Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Dermatology Drug Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 External Use

    • 4.3.2 Oral

    • 4.3.3 Injection

5 Dermatology Drug Market: Product Analysis

  • 5.1 Dermatology Drug Product Market Share Analysis, 2018 & 2026

  • 5.2 Dermatology Drug Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Dermatology Drug Market: Application Analysis

  • 6.1 Dermatology Drug Application Market Share Analysis, 2018 & 2026

  • 6.2 Dermatology Drug Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Psoriasis

    • 6.3.2 Skin Infections

    • 6.3.3 Acne

    • 6.3.4 Dermatitis

    • 6.3.5 Other

7 Dermatology Drug Market: Regional Analysis

  • 7.1 Dermatology Drug Regional Market Share Analysis, 2018 & 2026

  • 7.2 Dermatology Drug Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 AbbVie

    • 9.1.1 AbbVie Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Pfizer

    • 9.2.1 Pfizer Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Bayer

    • 9.3.1 Bayer Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Valeant

    • 9.4.1 Valeant Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Novartis

    • 9.5.1 Novartis Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Johnson & Johnson

    • 9.6.1 Johnson & Johnson Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 GlaxoSmithKline

    • 9.7.1 GlaxoSmithKline Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Bristol-Myers Squibb

    • 9.8.1 Bristol-Myers Squibb Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Galderma

    • 9.9.1 Galderma Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Merz Pharma

    • 9.10.1 Merz Pharma Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 LEO Pharma

    • 9.11.1 LEO Pharma Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

 

The List of Tables and Figures (Totals 91 Figures and 130 Tables)

  • Figure External Use Dermatology Drug market, 2015 - 2026 (USD Million)

  • Figure Oral Dermatology Drug market, 2015 - 2026 (USD Million)

  • Figure Injection Dermatology Drug market, 2015 - 2026 (USD Million)

  • Figure Psoriasis market, 2015 - 2026 (USD Million)

  • Figure Skin Infections market, 2015 - 2026 (USD Million)

  • Figure Acne market, 2015 - 2026 (USD Million)

  • Figure Dermatitis market, 2015 - 2026 (USD Million)

  • Figure Other market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Dermatology Drug market, by country, 2015 - 2026 (USD Million)

  • Table North America Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table North America Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table North America Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table Canada Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table Canada Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Europe Dermatology Drug market, by country, 2015 - 2026 (USD Million)

  • Table Europe Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table Europe Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table Europe Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table Germany Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table Germany Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table France Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table France Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table Italy Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table Italy Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table Spain Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table Spain Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Dermatology Drug market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table China Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table China Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table Japan Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table Japan Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table India Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table India Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Dermatology Drug market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table MEA Dermatology Drug market, by country, 2015 - 2026 (USD Million)

  • Table MEA Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table MEA Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table MEA Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Dermatology Drug market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Dermatology Drug market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Dermatology Drug market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table AbbVie Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Valeant Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Galderma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merz Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table LEO Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top